Susquehanna International Group’s Immunic IMUX Stock Holding History

Susquehanna International Group’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	102,826 +69,443	+208%	+$622K	﹤0.01%	7538
2025 Q4	$178K	Buy	+33,383	New	+$245K	﹤0.01%	11009
2025 Q2	–	Sell	-94,965	Closed	-$1.04M	–	13161
2025 Q1	$1.04M	Buy	94,965 +6,591	+7%	+$71.1K	﹤0.01%	7173
2024 Q4	$884K	Buy	88,374 +17,193	+24%	+$217K	﹤0.01%	7278
2024 Q3	$1.17M	Buy	71,181 +51,804	+267%	+$738K	﹤0.01%	6416
2024 Q2	$215K	Buy	19,377 +6,132	+46%	+$76.2K	﹤0.01%	10198
2024 Q1	$175K	Sell	13,245 -20,250	-60%	-$263K	﹤0.01%	10746
2023 Q4	$502K	Buy	33,495 +10,234	+44%	+$125K	﹤0.01%	8652
2023 Q3	$342K	Sell	23,261 -2,623	-10%	-$50.4K	﹤0.01%	9073
2023 Q2	$650K	Buy	25,884 +8,907	+52%	+$149K	﹤0.01%	7701
2023 Q1	$253K	Sell	16,977 -3,284	-16%	-$61K	﹤0.01%	10088
2022 Q4	$284K	Buy	20,261 +18,084	+831%	+$493K	﹤0.01%	9230
2022 Q3	$69K	Sell	2,177 -2,601	-54%	-$109K	﹤0.01%	11998
2022 Q2	$166K	Buy	4,778 +3,486	+270%	+$223K	﹤0.01%	10900
2022 Q1	$146K	Buy	+1,292	New	+$150K	﹤0.01%	11582
2021 Q3	–	Sell	-3,793	Closed	-$373K	–	13124
2021 Q2	$465K	Sell	3,793 -2,033	-35%	-$281K	﹤0.01%	9757
2021 Q1	$929K	Buy	5,826 +3,123	+116%	+$530K	﹤0.01%	7938
2020 Q4	$413K	Buy	2,703 +607	+29%	+$109K	﹤0.01%	8673
2020 Q3	$389K	Buy	+2,096	New	+$343K	﹤0.01%	8199
2019 Q1	–	Sell	-147	Closed	-$12.9K	–	9316
2018 Q4	$11K	Sell	147 -681	-82%	-$79.7K	﹤0.01%	8736
2018 Q3	$91K	Buy	+828	New	+$2.16M	﹤0.01%	8644
2018 Q2	–	Sell	-486	Closed	-$1.12M	–	9970
2018 Q1	$1.32M	Buy	486 +330	+212%	+$757K	﹤0.01%	4686
2017 Q4	$371K	Buy	+156	New	+$345K	﹤0.01%	7197
2017 Q3	–	Sell	-231	Closed	-$301K	–	9191
2017 Q2	$268K	Buy	+231	New	+$308K	﹤0.01%	7773
2017 Q1	–	Sell	-120	Closed	-$210K	–	9414
2016 Q4	$210K	Buy	+120	New	+$263K	﹤0.01%	8583
2015 Q4	–	Sell	-59	Closed	-$193K	–	9656
2015 Q3	$96K	Buy	+59	New	+$295K	﹤0.01%	9165
2014 Q3	–	Sell	-24	Closed	-$258K	–	9663
2014 Q2	$258K	Buy	+24	New	+$168K	﹤0.01%	8633

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Susquehanna International Group's IMUX Position: Q1 2026 in Review

Susquehanna International Group increased its Immunic (IMUX) stake by 208% in Q1 2026, buying an estimated $622K and bringing the position to 102,826 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #7538.

Susquehanna International Group first reported a position in IMUX in Q2 2014 and has held it in 27 quarters since. The position peaked at $1.32M in Q1 2018. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Susquehanna International Group held 102,826 shares of Immunic worth $1.14M as of Q1 2026.
Susquehanna International Group bought 69,443 Immunic shares in Q1 2026, an estimated $622K.
Immunic made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7538 holding.
Susquehanna International Group first reported a position in Immunic in Q2 2014 and has held it in 27 quarters since.
Susquehanna International Group's Immunic position peaked at $1.32M in Q1 2018.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.